PACB - Pacific Biosciences of California, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
82,487
78,626
93,468
90,714
92,782
Cost of Revenue
55,097
53,530
58,809
46,554
39,332
Gross Profit
27,390
25,096
34,659
44,160
53,450
Operating Expenses
Research Development
61,620
62,594
65,324
67,617
60,440
Selling General and Administrative
79,021
63,489
59,119
47,787
45,187
Total Operating Expenses
140,641
126,083
124,443
115,404
82,584
Operating Income or Loss
-113,251
-100,987
-89,784
-71,244
-29,134
Interest Expense
2,561
2,423
2,921
3,234
2,926
Total Other Income/Expenses Net
970
848
516
103
364
Income Before Tax
-114,842
-102,562
-92,189
-74,375
-31,696
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-114,842
-102,562
-92,189
-74,375
-31,696
Net Income
-114,842
-102,562
-92,189
-74,375
-31,696
Net Income available to common shareholders
-114,842
-102,562
-92,189
-74,375
-31,696
Reported EPS
Basic
-
-0.76
-0.87
-0.83
-0.42
Diluted
-
-0.76
-0.87
-0.83
-0.42
Weighted average shares outstanding
Basic
-
135,094
105,682
89,148
75,614
Diluted
-
135,094
105,682
89,148
75,614
EBITDA
-
-92,924
-80,826
-67,266
-25,093